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The mature mouse utricle, which detects
linear acceleration, displays limited
regeneration, but whether function
returns is unknown. Sayyid et al. show
that regenerated hair cells appear and
mature over months, resulting in a limited,
unsustained functional recovery. Atoh1
overexpression enhances regeneration
and leads to a sustained recovery of
vestibular function.
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SUMMARY

Utricular hair cells (HCs) are mechanoreceptors
required for vestibular function. After damage, regeneration of mammalian utricular HCs is limited and
regenerated HCs appear immature. Thus, loss of
vestibular function is presumed irreversible. Here,
we found partial HC replacement and functional recovery in the mature mouse utricle, both enhanced
by overexpressing the transcription factor Atoh1.
Following damage, long-term fate mapping revealed
that support cells non-mitotically and modestly regenerated HCs displaying no or immature bundles.
By contrast, Atoh1 overexpression stimulated proliferation and widespread regeneration of HCs exhibiting elongated bundles, patent mechanotransduction
channels, and synaptic connections. Finally, although
damage without Atoh1 overexpression failed to
initiate or sustain a spontaneous functional recovery,
Atoh1 overexpression significantly enhanced both
the degree and percentage of animals exhibiting sustained functional recovery. Therefore, the mature,
damaged utricle has an Atoh1-responsive regenerative program leading to functional recovery, underscoring the potential of a reprogramming approach
to sensory regeneration.
INTRODUCTION
Sensory hair cells (HCs) are essential for vestibular function. In
contrast to the cochleae, where no regeneration occurs (Bermingham-McDonogh and Reh, 2011), vestibular organs gradually replace lost HCs (Forge et al., 1993). The mammalian utricle,
a vestibular organ that detects linear acceleration, displays new,
immature HCs months after damage (Forge et al., 1993, 1998;
Kawamoto et al., 2009). However, regeneration occurs almost
exclusively in the peripheral zone termed the extrastriola,
whereas the central striolar region fails to replace HCs (Golub
et al., 2012). Many regenerated HCs bear short stereociliary bundles reminiscent of nascent, immature HCs (Forge et al., 1993;
Kawamoto et al., 2009). Although vestibular HCs consist of two

subtypes (types I and II), regenerated HCs have been reported
to be almost exclusively type II (Bucks et al., 2017; Golub
et al., 2012). Because regeneration is limited, loss of vestibular
function is at present presumed irreversible.
Unlike the mammalian utricle, support cells in regenerating
non-mammalian sensory organs mitotically regenerate both
types of vestibular HCs to near complete levels throughout the
organ (Roberson et al., 1992; Weisleder and Rubel, 1992), and
function is restored as measured directly via vestibular physiology (Carey et al., 1996; Jones and Nelson, 1992). In mice,
although behavior assessment using rotarod testing suggests
some improvement of vestibular function months after injury
(Schlecker et al., 2011), guinea pigs damaged by aminoglycosides failed to recover function as measured by vestibular
evoked potential (VsEP) responses (Bremer et al., 2014). Therefore, it is unclear whether mammalian vestibular HC regeneration
leads to restoration of function.
One proposed mechanism to enhance HC regeneration is via
overexpression (OE) of Atoh1, a basic-helix-loop-helix transcription factor required for differentiation of developing HCs
(Bermingham et al., 1999). In the developing cochlea and utricle, Atoh1 OE induced ectopic HC formation in vivo (Gao
et al., 2016; Kelly et al., 2012; Liu et al., 2012). On the other
hand, several studies have found limited to no ectopic HC formation after Atoh1 OE in the mature cochlea and utricle in vivo,
indicating an age-related decline in Atoh1 responsiveness (Atkinson et al., 2014; Gao et al., 2016), which may be enhanced
in vitro or after damage (Schlecker et al., 2011; Shou et al.,
2003). In addition, HCs normally downregulate Atoh1 as they
mature (Lanford et al., 2000), and constitutive Atoh1 OE in the
cochlea prevents maturation (Liu et al., 2012). At present, it remains unclear whether transient or constitutive Atoh1 OE is
effective in inducing HC regeneration and functional recovery
in the mature mammal.
Here, we show that HCs regenerate and partially mature in
the damaged, mature utricle, where Atoh1 OE stimulated proliferation of support cells and regeneration of HCs displaying
elongated stereocilia and open mechanotransduction channels. Moreover, Atoh1 OE animals demonstrated more robust
VsEP responses relative to damage-only animals. Thus, the
damaged, mature mammalian utricle is uniquely competent
to respond to Atoh1 OE to enhance both the number and
maturation of regenerated HCs, resulting in improved vestibular function.
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Figure 1. Plp1+ Support Cells Regenerate HCs
(A) P30 wild-type mice were treated with IDPN, and utricles were examined 1 week later. Undamaged controls were injected with saline. Myosin7a+ HCs were
identified in the striola (dashed lines) and extrastriola.
(B) Characteristic VsEP waveforms from undamaged animals (threshold 0.4 g/ms, red) were lost in IDPN-treated animals.
(C) IDPN-treated animals displayed significantly higher thresholds than undamaged controls.
(D) Rapid loss followed by gradual repopulation of HCs.
(E) Schematic of transgenic approach to trace support cells.
(F) Quantification shows significant increase in total HC number in the entire organ by 180 days after damage.

(legend continued on next page)

Cell Reports 28, 312–324, July 9, 2019 313

RESULTS
HCs Spontaneously Regenerate in the Mature Mouse
Utricle
We first developed and characterized a damage protocol using the
vestibulotoxin IDPN (3,30 -iminodipropionitrile) (Soler-Martin et al.,
2007). We administered IDPN to postnatal 30-day-old (P30)
mice, an age when utricular function is deemed mature (Jones
and Jones, 1999), and found that a moderate dose (4 mg/g) caused
68.2% and 76.3% HC loss in the extrastriola and striola, respectively, 7 days later (Figure 1A; Figures S1A–S1C).
VsEPs (vestibular evoked potentials) are compound action potentials elicited by linear acceleration in the naso-occipital axis
(Jones et al., 2001, 2011). Threshold, latency, and amplitude of
each waveform represent the overall organ sensitivity, timing of
neural transmission, and size and synchrony of the activated
neuronal population, respectively (Nazareth and Jones, 1998).
Mutant mice with deficient stereociliary bundles or with HC loss
demonstrate elevated thresholds, prolonged latencies, and
decreased amplitudes (Geng et al., 2009; Krey et al., 2016), indicating that functional HCs are critical for VsEP responses. Seven
days after IDPN treatment, animals demonstrated no detectable
responses (Figure 1B). Overall, IDPN-treated animals showed
significantly elevated thresholds, longer latencies, and smaller
amplitudes compared with undamaged controls (Figure 1C; Figures S1D and S1E). Thus, IDPN treatment effectively decreased
HC survival and abolished utricular function.
To assess for HC regeneration, we examined IDPN-treated
animals with no detectable VsEP thresholds and found a gradual
repopulation of HCs in the extrastriola but not the striola
30–180 days later (Figure 1D; Figure S1F), a finding consistent
with other damage paradigms (Golub et al., 2012; Lin et al.,
2011). Extrastriolar HC density increased from 29.3% of agematched controls at 7 days to 56.8% at 180 days after damage
(Table S1). Overall, total HC counts increased from 21.8%
of age-matched controls at 7 days to 47.8% at 180 days
(Figure 1F).
To label newly regenerated HCs, we traced support cells using
Plp1CreERT/+; Rosa26tdTomato/+ mice (Plp1-Tomato; Figure 1E).
After IDPN administration at P30 to ablate HCs, tamoxifen was
given at P32 to activate Cre recombinase in support cells, labeling 75.0% of extrastriolar and 45.0% of striolar Sox2+ support
cells in both undamaged and damaged organs (Figures S2A
and S2B). In the undamaged utricle, we found rare tdTomato+,
Myosin7a+ HCs post-tamoxifen injection, corroborating previous reports of rare HC turnover (Figure S2C; Bucks et al.,
2017). Seven days post-IDPN treatment, many traced support
cells but no traced HCs were found. Mice injected with vehicle
control without tamoxifen had minimal recombination (<1%)
post-IDPN injection, indicating a low Cre recombinase leakiness
as previously reported (Figure S2D; McGovern et al., 2017). After
damage, traced HCs significantly increased in the extrastriola
over time (Figures 1G and 1H; Figure S2E). In the striola, the in-

crease in traced HCs was small, and the total number of HCs
did not significantly increase over time (Figure S2E; Table
S1). Together, these data indicate that support cells, particularly
those in the extrastriola, contribute to HC regeneration in the
mature, damaged mouse utricle.
Atoh1 Enhances HC Regeneration
During development, the transcription factor Atoh1 is essential
for HC specification, and expression is downregulated postnatally (Bermingham et al., 1999; Lanford et al., 2000). In the undamaged mature utricle, HCs and support cells rarely express
Atoh1 (fewer than two cells per 10,000 mm2) (Figure S3A).
Atoh1 was upregulated in support cells 7–14 days after IDPN
treatment (Figures S3B and S3D). We postulated that incomplete, spontaneous regeneration is attributed to insufficient
Atoh1 upregulation and hypothesized that Atoh1 OE could
enhance HC regeneration. To test this, we used Plp1CreERT/+;
CAGflox-Atoh1-HA/+ (henceforth Plp1-Atoh1-HA) mice (Liu et al.,
2012), in which tamoxifen injection induces constitutive Atoh1
OE in support cells, which are in turn fate-mapped via the hemagglutinin (HA) tag (Figure 2A). Littermate controls sharing the
same genetic background were used as damage-only controls.
Without damage, tamoxifen rarely induced Atoh1-HA expression and failed to stimulate ectopic HC formation (Figures S3E–
S3H), despite robust Cre activation as detected by tdTomato
expression (Figure S3I). In contrast, tamoxifen induced robust
Atoh1-HA expression in support cells in the damaged utricle
(Figure S4A; Table S2). Moreover, significantly more regenerated
HCs were observed over time, reaching 80.4% of undamaged,
age-matched controls 180 days post-damage (Figures 2B and
2C). Although HCs regenerated mainly in the extrastriola of
damage-only utricles (Figures 2D and 2E; Table S1), Atoh1 OE,
damaged utricles showed significantly more HCs in both the extrastriola and striola (Figures 2D–2F; Table S1), resulting in significantly more HCs overall.
Atoh1 OE, damaged utricles showed a gradual and significant
increase in traced, HA+ HCs over time (Figures 2D–2F; Tables S1
and S2), suggesting that Atoh1 OE increased support cell conversion into HCs only after damage. In support of this notion,
Atoh1 OE significantly increased Atoh1+ support cells only after
damage (Figures S3B–S3D). Together, these results suggest
that support cells in the damaged, mature utricle are competent
to respond to Atoh1 OE and regenerate more HCs.
Atoh1 OE Increases Proliferation
The mature mammalian utricle is mitotically quiescent and
remains so after damage. To assess for proliferation early
(1 week) and late (1–3 months) post-damage, we immunostained for Ki67 or injected EdU intraperitoneally 3 days per
week for 4 weeks. We detected almost no labeled support
cells in either damage-only or Atoh1 OE undamaged utricles
(Figures 2G–2I; Table S3). By contrast, Atoh1 OE, damaged
utricles had Ki67+/Sox2+ (4.4 ± 9.6 per utricle, n = 10) and

(G) Traced HCs increase post-IDPN treatment (arrowheads). Orthogonal projection showing traced HCs (asterisks) 180 days post-damage.
(H) Quantification of traced HCs.
Student’s t test (C), one-way ANOVA with Tukey’s multiple comparisons test (F and H), n for animals (C) and utricles (F and H). **p < 0.01, ***p < 0.001. Data are
shown as mean ± SD.
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EdU+/Sox2+ (20.9 ± 37.3, n = 19) support cells primarily in the
striola 30 days post-damage (Figure 2J; Figure S4B). Overall,
among the 19 utricles analyzed 30 days post-damage and
Atoh1 OE, 7 showed proliferating cells, with a small subset of
EdU+ cells expressing Myosin7a (Figure 2J). Significantly
more EdU+/Sox2+ support cells were found in Atoh1 OE,
damaged utricles than in damage-only utricles (0.0 ± 0.0,
n = 3, p < 0.05). Most EdU+ cells were not tdTomato or HA
labeled (Figure 2J; Figures S4B and S4C), suggesting that
Atoh1 may have stimulated proliferation in a non-cell-autonomous manner. Ninety days after damage and Atoh1 OE, many
EdU+/Sox2+ but no Ki67+/Sox2+ cells were found (Figure 2K),
suggesting that mitotic cells did not degenerate and mitosis
was transient. These data demonstrate that Atoh1 OE induces
support cell proliferation of the damaged mouse utricle.
Atoh1 Enhances Stereociliary Bundle Formation
HCs are equipped with stereociliary bundles that lengthen as
they mature (Geleoc and Holt, 2003). Months after injury, the
mammalian utricle contains HCs bearing short bundles reminiscent of nascent HCs (Forge et al., 1993). We sought to assess the
bundles, a presumed surrogate marker of maturation (Ellwanger
et al., 2018), of regenerated HCs by labeling for F-actin postdamage (Figure 3A). The apical surface of undamaged utricles
is composed of a sheet of HCs with dense, mature stereociliary
bundles (Figure 3B). In contrast, 7 days post-damage, most bundles have disappeared, as >77% of HCs are lost (Figures S5A
and S5B). At 30 days, 69.8% of traced, regenerated HCs lacked
bundles (i.e., bundleless), while 30.2% displayed a spectrum of
bundle maturity, most of which appeared short (Figures 3C,
3F, S5C, and S5D). In contrast, bundles were detected on
more traced HCs 90–180 days post-damage (Figures 3C and
3F). In comparison, 83.4% of untraced HCs, which represent
surviving HCs and some newly regenerated but untraced HCs,
displayed bundles 30 days after damage (Figure 3G). By
180 days, 96.4% of untraced HCs displayed bundles (Figures
3B and 3G). Thus, our data suggest that the apical maturation
of regenerated HCs was incomplete, even after a prolonged
recovery post-injury.
Constitutive Atoh1 OE restricts HC maturation in the cochlea,
resulting in a lack of terminal differentiation markers and bundle

development (Atkinson et al., 2014). To determine whether Atoh1
OE regenerated HCs in the utricle can mature, we first examined
Atoh1 OE, undamaged tissues and found no bundle abnormalities (Figure 3D). When examining Atoh1 OE, damaged tissues
at 30 days, we found that like damage-only tissues, >50% of
traced, regenerated HCs were bundleless (Figures 3E and 3F).
Unexpectedly, significantly more Atoh1 OE traced HCs displayed bundles 90 (94.0%) and 180 days (95.5%) post-damage
compared with damage-only HCs (Figures 3E and 3F).
To assess for functionality of regenerated HCs, we applied
Texas red-tagged gentamicin (GTTR), which selectively permeates mechanotransduction channels (Alharazneh et al., 2011).
In Atoh1 OE, undamaged utricles, 83.8% of HCs were GTTR+,
and no HA+ HCs were detected (Figures 3H and 3J). In contrast,
numerous HA+ HCs were present throughout the Atoh1 OE,
damaged utricle (Figure 3I), in which 64.6% of Myosin7a+/HA
HCs and 32.6% of Myosin7a+/HA+ incorporated GTTR (Figures
3I and 3J). Taken together, these data suggest that Atoh1 OE regenerated HCs matured and gained the ability to take up GTTR,
indicative of patent mechanotransduction channels. Moreover,
Atoh1 OE promotes the development of mature-appearing bundles in regenerated HCs.
Regenerated HCs Differentiate into HC Subtypes
The mature mouse utricle is composed of two main subtypes of
HCs, estimated to be 55% type I and 45% type II (Desai et al.,
2005). Type I HCs express osteopontin (OPN) at the apical
neck and are innervated by flask-shaped calyces, whereas
type II HCs express a membranous pattern of annexin A4
(ANXA4) and are innervated by boutons (Figure 4C; McInturff
et al., 2018). We found that progressively more traced HCs expressed OPN and fewer expressed ANXA4 after damage (Figures 4A, 4D, 4E, 4H, and 4I). By 180 days post-damage, with
traced regenerated HCs significantly increased, the proportion
of OPN+ traced HCs increased, whereas that of ANXA4+ traced
HCs decreased (Figures 4A, 4D, 4E, 4H, and 4I), suggesting that
more HCs with a type I phenotype regenerated over time. In support of this notion, traced HCs associated with Tuj1+ calyces
increased from 5.5% at 30 days to 12.9% 180 days after damage
(Figure 4J; Figure S6A). Altogether, our data suggest that regenerated HCs consist of both type I and type II HCs.

Figure 2. Atoh1 OE Enhances HC Regeneration and Proliferation
(A) Schematic for tracing and Atoh1 OE in Plp1+ support cells. Atoh1 OE cells were detected via tdTomato/HA labeling.
(B) Robust repopulation of Atoh1 OE, damaged utricles with tdTomato+ HCs. Boxes represent extrastriolar and striolar regions where high-magnification images
were taken.
(C) Quantification of total HCs post-treatment (IDPN or saline) and Atoh1 OE.
(D) Representative images of the extrastriola and striola after damage alone or with Atoh1 OE. No HA+ cells were identified after damage alone. HA+ HCs were
detected after damage and Atoh1 OE.
(E and F) Extrastriolar (E) and striolar (F) HC density in undamaged, damaged only, Atoh1 OE, undamaged, and Atoh1 OE, damaged tissues.
(G) Schematic to ablate HCs, fate-map Plp1+ support cells, and Atoh1 OE. EdU was given to label mitotic cells.
(H and I) No Ki67+ or EdU+ cells were detected in the sensory epithelium of either Atoh1 OE, undamaged (H) or damage-only (I) utricles at 30 days.
(J) Ki67+ and EdU+ support cells were detected 30 days after damage and Atoh1 OE, particularly in the striola. tdTomato-positive (arrow) and tdTomato-negative
(arrowheads) proliferative (Ki67+ or EdU+) cells. Drawings depicting location of proliferative Sox2+ (green) and Myosin7a+ (black) cells; black boxes represent
striolar regions where images were captured.
(K) Ninety days after damage and Atoh1 OE, many EdU+ cells were still detected in the striola, consisting of EdU+/Sox2+/Myosin7a support cells (arrowheads)
and EdU+/Sox2+/Myosin7a+ HCs (arrows).
One-way ANOVA with Tukey’s multiple comparisons test (C), two-way ANOVA with Tukey’s multiple comparisons test (E and F), n for utricles. *p < 0.05; **p <
0.01, ***p < 0.001. Data are shown as mean ± SD.

316 Cell Reports 28, 312–324, July 9, 2019

(legend on next page)

Cell Reports 28, 312–324, July 9, 2019 317

In the Atoh1 OE, damaged utricle, traced HCs predominantly
(>93%) expressed the type II HC marker ANXA4 across all time
points examined (Figures 4B, 4G, and 4I). Despite an increase
in regenerated HCs as a result of Atoh1 OE, the proportion of
OPN+ traced HCs remained low (Figures 4B, 4F, and 4H).
Moreover, traced HCs rarely displayed Tuj1+ calyces (Figure 4J).
As controls, untraced HCs from damage-only and Atoh1
OE, damaged utricles showed a similar percentage of OPN,
ANXA4, and Tuj1 expression across time points (Figures S6B–
S6E). All traced, regenerated HCs in both damage-only and
Atoh1 OE, damaged utricles were juxtaposed to Tuj1+ neurites
and appeared innervated. They also had comparable expression
of the pre- and post-synaptic markers Ctbp2 and Shank1,
respectively (Figure S6F). These data suggest that Atoh1 OE regenerated HCs acquired a type II HC phenotype at the expense
of type I HCs, displayed synaptic elements and appeared
innervated.
Atoh1 OE Improves Recovery of Vestibular Function
The avian utricle can regenerate both type I and type II HCs to
regain VsEP responses (Jones and Nelson, 1992). We sought
to determine whether spontaneous regeneration—in which we
have observed a modest regeneration of both type I and type II
HCs—or Atoh1-enhanced regeneration—in which we observed
type II HC phenotypes, elongated stereociliary bundles, and
neural integration—leads to a recovery of vestibular function of
the damaged, mature mouse utricle. After initial loss of vestibular
function at 7 days, VsEP responses were measured 30, 90, and
180 days after IDPN treatment (Figure 5A). Undamaged, control
animals displayed consistent VsEP thresholds at all time points,
and Atoh1 OE did not affect thresholds in the undamaged control
(Figures 5B and 5C). Many IDPN-treated animals continued to
have no measurable response 30 days after damage but regained a partial recovery of responses by 180 days (Figure 5B).
These responses, however, remained abnormal as thresholds
were higher, latencies longer, and amplitudes smaller than
those of age-matched controls (Figures 5B and 5C; Figures
S7B and S7C).
Average VsEP thresholds significantly improved from
7–180 days after IDPN treatment but remained significantly
higher than undamaged control levels (Figure 5C). After an initial
improvement 30–90 days post-damage, average thresholds of
damage-only animals worsened at 180 days, suggesting that

improvement in responses may be temporary and unsustained
over time. In comparison, average thresholds of Atoh1 OE,
damaged animals were significantly better than damage-only
animals at 180 days (Figure 5C). Additionally, significantly more
Atoh1 OE, damaged animals displayed VsEP responses at
180 days than damage-only animals (Figure 5D).
Both latencies and amplitudes significantly improved over
time but remained significantly worse than age-matched controls in both damage-only and Atoh1 OE, damaged animals at
180 days (Figures S7B–S7D), suggesting that the timing of neural
transmission was prolonged, and resynchronization of vestibular
ganglia firing remained incomplete. Latencies and amplitudes
did not significantly differ between damage-only and Atoh1
OE, damaged animals (Figure S7D), suggesting that neural connections of Atoh1 OE regenerated HCs were comparable with
those of regenerated HCs in damage-only organs. In support
of these results, we detected no gross differences in synaptic
protein (Ctbp2 and Shank1) expression in HCs from the two
groups (Figure S6F). When comparing HC densities in utricles
from individual damaged animals to their corresponding VsEP
thresholds, we found a significant correlation (Figures 5E and
5F), suggesting that HC regeneration may have contributed to
the functional recovery.
To follow the vestibular function of individual animals over time,
we serially measured VsEPs in a subset of animals 7–180 days
post-treatment (11 control and 29 damaged for spontaneous
regeneration, 5 control and 19 damaged for Atoh1-enhanced
regeneration). As expected, all control animals displayed stable
thresholds (Figures 5G and 5H). After an initial loss of thresholds
in damaged-only animals, we found three trajectories for vestibular function: (1) no recovery (17.2%), (2) sustained recovery
(37.9%), and (3) unsustained recovery (44.8%) as defined by an
initial recovery of thresholds followed by a subsequent loss by
180 days (Figure 5G; Table S4). Although >50% of serially
analyzed mice recovered VsEP thresholds at 30 and 90 days,
<40% of mice had detectable thresholds by 180 days (Figures
5D and 5G). Together, these data suggest that during spontaneous regeneration, 82.8% of animals (24 of 29) are able to
partially recover vestibular function, but 54.2% of these animals
(13 of 24) failed to recover function in a sustained manner. Among
the 19 Atoh1 OE, damaged mice, 21.1% demonstrated no recovery, 68.4% sustained recovery, and 10.5% unsustained recovery
(Figure 5H; Table S4). In comparison with damage-only animals,

Figure 3. Atoh1 OE Enhances Stereociliary Bundle Formation
(A) Schematic showing the strategy for ablating HCs, tracing and Atoh1 OE in Plp1+ support cells. Plp1CreERT/+; Rosa26tdTomato/+ mice served as controls.
(B) Undamaged utricles contained many HCs with healthy and long bundles and no traced HCs. Dashed boxes represent areas from which high-magnification
images at the hair bundle and cell body levels are shown.
(C) Thirty days after damage, many HCs were lost, and the few traced HCs (dashed lines) present displayed no stereociliary bundles. Ninety and 180 days after
damage, more traced HCs appeared, many displaying stereociliary bundles.
(D) Atoh1 OE, undamaged control utricle show normal HC density and bundle morphology.
(E) With damage and Atoh1 OE, many more traced HCs (dashed lines) gradually appeared, most noticeably at 90 and 180 days. Bundles were detected in most
traced HCs.
(F and G) Percentage of traced (F) and untraced (G) HCs in damage-only and Atoh1 OE, damaged utricles displaying stereociliary bundles months after damage.
(H and I) Representative images of Atoh1 OE, undamaged (H) and damaged (I) utricles at 180 days. Utricles were incubated with GTTR. In undamaged tissues, all
HCs were negative for HA, and most were GTTR+ (asterisks). With damage and Atoh1 OE, GTTR labeling was observed in Myosin7a+/HA+ (arrowheads) and
Myosin7a+/HA HCs (asterisks).
(J) Quantification of Myosin7a+/GTTR+ HCs in Atoh1 OE, undamaged and damaged utricles at 180 days.
c2 test, n for HCs. *p < 0.05; **p < 0.01, ***p < 0.001. Data are shown as mean ± SD.
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Figure 4. Atoh1 OE Increases Regeneration of Neurally Integrated Type II HCs
(A and B) Damaged-only (A) and Atoh1 OE, damaged (B) utricles demonstrating osteopontin+ (OPN) type I HCs and annexin A4+ (ANXA4) type II HCs. After
damage and Atoh1 OE, the utricle was densely populated by HCs, with a noticeable loss of OPN expression.
(C) Diagram depicting amphora-shaped type I HCs expressing OPN in the neck region and goblet-shaped type II HCs expressing membranous ANXA4.
(D) Representative images of damaged utricles at 180 days showing traced, Myosin7a+, OPN+ type I HCs (asterisk) with Tuj1+ calyx (orthogonal view highlighting
OPN and Tuj1 labeling). Traced HCs negative for OPN were also noted.
(E) Many traced Myosin7a+, ANXA4+ type II HCs (asterisk) without Tuj1+ calyces were found, alongside traced HCs negative for ANXA4.
(F) After damage and Atoh1 OE, there was a noticeable loss of OPN expression and Tuj1+ calyces among traced Myosin7a+ HCs (orthogonal view illustrating loss
of OPN labeling). A rare traced Myosin7a+, OPN+ type I HC (asterisk) identified with a Tuj1+ calyx.
(G) Most traced Myosin7a+ HCs expressed ANXA4 without Tuj1+ calyces. High-magnification images showing traced HCs expressing ANXA4+ (asterisks).
(H–J) Quantification of traced HCs expressing OPN (H), ANXA4 (I), and displaying calyces (J).
Two-way ANOVA with Tukey’s multiple comparisons test, n for utricles. *p < 0.05; **p < 0.01, ***p < 0.001. Data are shown as mean ± SD.
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Figure 5. Atoh1 OE Enhances Functional Recovery of the Damaged, Mature Utricle
(A) Schematic showing experiments measuring VsEPs in control and damaged mice with and without Atoh1 OE.
(B) Representative VsEP traces of control animals 180 days after saline treatment (threshold 0.5 g/ms, red) and animals 30 (no responses) and 180 days after IDPN
treatment (threshold 1.0 g/ms, red).
(C) VsEP thresholds of saline-treated (red), damage-only (black), Atoh1 OE, saline-treated (purple), and Atoh1 OE, damaged (blue) animals.
(D) Percentage of animals with detectable VsEP responses.
(E and F) Significant correlation between VsEP thresholds of damage-only (E) and Atoh1 OE, damaged (F) animals and utricular HC density at 180 days posttreatment.
(G) Serial measurements of individual animals show three patterns: no recovery (gray), unsustained recovery (purple), and sustained recovery (black). Control
animals in red.

(legend continued on next page)
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significantly more animals showed a sustained recovery of VsEP
responses (Figure 5I). In sum, the mature mouse utricle can
partially regain function following damage, but the recovery is
commonly unsustained. In contrast, Atoh1 OE leads to a sustained recovery of vestibular function.
DISCUSSION
The mature mammalian cochlea fails to regenerate lost HCs,
leading to permanent hearing loss. Although HCs regenerate in
the mature mammalian vestibular organs (Forge et al., 1993;
Golub et al., 2012; Li et al., 1995; Warchol et al., 1993), whether
this limited degree of regeneration leads to a recovery of vestibular function was previously unknown. Here, we demonstrate
that the mature mouse utricle is capable of spontaneous and
modest regeneration of HCs and recovery of vestibular function
over a 6 month time course. Moreover, functional recovery was
in part unsustained, leading to a detectable VsEP response
in <40% of animals 180 days post-damage. Atoh1 OE significantly increased HC regeneration throughout the utricle, stimulated proliferation, and promoted bundle formation. Overall,
Atoh1 OE improved VsEP responses leading to sustained functional recovery in more animals (Figure S8). Collectively, we
have revealed that Atoh1 OE promotes vestibular regeneration
and functional recovery.
Incomplete Bundle Maturation in Regenerated HCs
We found that regenerating HCs displayed nascent or no bundles, starkly contrasting their more mature basolateral features
(HC subtype markers, synaptic proteins, and nerve terminals).
In the developing utricle, specified HCs first acquire bundles
and mechanotransduction and subsequently basolateral potassium currents and nerve terminals characteristic of HC subtype
specialization (Geleoc et al., 2004). Therefore, unlike developing
HCs, apical bundles in regenerating HCs fail to mature despite
grossly normal synaptic elements and innervation (Atkinson
et al., 2015; Zheng and Zuo, 2017; Wang et al., 2019). Such discrepancies in the degrees of maturation of bundles and basolateral features were previously observed in ectopic HCs in the
neonatal and mature cochlea and HCs derived from embryonic
stem cells (Gubbels et al., 2008; Oshima et al., 2010; Walters
et al., 2017).
Damage-Induced Atoh1 Responsiveness
Atoh1 induces ectopic HC formation in the immature cochlea and
utricle (Gao et al., 2016; Kelly et al., 2012; Liu et al., 2012). However, the efficacy of Atoh1 in the mature inner ear is rather limited,
as the few Atoh1 OE HCs failed to mature (Atkinson et al., 2014;
Liu et al., 2012). After damage, the mature cochlea remains minimally responsive to Atoh1 (Atkinson et al., 2014; Liu et al., 2012).
Our results indicate that the damaged mature utricle, but not the
undamaged organ, is competent to respond to Atoh1 OE.

Atoh1-HA was rarely detected in the undamaged utricle, but
HA-negative cells could be expressing HA at low levels, as HA
immunostaining is less sensitive than tdTomato expression.
Higher Atoh1-HA levels in the Atoh1 OE, damaged organs may
have increased regeneration by enhancing endogenous Atoh1
levels, as the two can correlate at transcription levels during
regeneration (Yamashita et al., 2018). Further investigation
examining transcription factor networks in the damaged mature
utricle can help identify mechanisms of Atoh1 responsiveness.
Multiple Effects of Atoh1 OE on Vestibular Regeneration
Constitutive expression of Atoh1 stimulates ectopic HC formation, yet new HCs fail to fully mature, presumably because of a
lack of Atoh1 downregulation (Liu et al., 2012; Yamashita et al.,
2018). Our data suggest that sustained Atoh1 OE enhances,
rather than prevents, apical maturation of regenerating HCs.
Forced expression of Atoh1 was previously reported to induce
bundle repair in noise-damaged cochlear HCs (Yang et al.,
2012), lending additional evidence that Atoh1 OE can promote
bundle formation.
Atoh1 OE also stimulated support cell proliferation, a response
previously noted in the neonatal mouse and avian cochlea (Kelly
et al., 2012; Lewis et al., 2012). Proliferative cells primarily occupied the striola, suggesting regional differences in proliferative
capacity. Previous work on the neonatal mouse utricle showed
that damage induced cell cycle re-entry in Lgr5+ striolar support
cells (Wang et al., 2015). Because most proliferative cells were
not traced, Atoh1 OE may have stimulated mitosis in a noncell-autonomous manner while promoting HC specification and
maturation in a cell-autonomous fashion. Comparing Atoh1
target genes in vestibular and cochlear tissues (Yamashita
et al., 2018) should shed light on possible mechanisms differentiating their responsiveness.
The degree of HC regeneration induced by Atoh1 OE exceeds
that of spontaneous regeneration, although it remained incomplete relative to undamaged tissues. Because our transgenic
approach constitutively introduced a single, extra copy of
Atoh1, it is possible that other strategies to overexpressing
Atoh1 (e.g., transient and/or multiple copies of Atoh1) may
induce different effects.
Vestibular Regeneration and Function
VsEP responses are thought to originate largely from the activation of type I HCs because of their larger conductances (Kim
et al., 2011). However, during avian vestibular regeneration, responses return within 7–14 days after damage, when predominantly type II HCs with nascent stereociliary bundles repopulate
the epithelium and before type I HCs emerge (Dye et al., 1999;
Jones and Nelson, 1992; Weisleder et al., 1990). In our study,
Atoh1 OE enhanced regeneration of predominantly type II HCs,
leading to improved, sustained functional recovery. This suggests that utricles containing mainly type II HCs may also

(H) Serial measurements of individual animals show three patterns: no recovery (gray), unsustained recovery (purple), and sustained recovery (blue). Control
animals in red.
(I) Percentage of animals in each recovery group at 180 days after IDPN treatment.
Two-way ANOVA with Tukey’s multiple-comparisons test (C), c2 test (D and I), linear regression for Pearson correlation coefficient (E and F), n for animals. *p <
0.05; **p < 0.01, ***p < 0.001. Data are shown as mean ± SD.
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function to detect linear acceleration and contribute to VsEP
responses. In both spontaneous and Atoh1-enhanced regeneration, HC number correlated with vestibular responses. However,
we did not observe a threshold of HC number above which
vestibular function more readily recovers.
In the late phase of recovery of vestibular function, we propose
that unsustained recovery may have resulted from dysfunction
and subsequent loss of regenerated HCs. Regenerating HCs
may be susceptible to delayed degeneration, a phenomenon
previously observed in the regenerating neonatal cochlea (Atkinson et al., 2018; Cox et al., 2014). Alternatively, insufficient levels
of Atoh1 may have caused unsustained recovery during regeneration, and Atoh1 OE may have promoted the maturation and
survival of regenerated HCs, which in turn converted animals
with unsustained recovery to a sustained recovery pattern.
Moreover, the recovery of surviving HCs, striolar HC regeneration and support cell proliferation as a result of Atoh1 OE may
have also contributed to improved vestibular function. Other
potential contributing factors to the recovery of vestibular function include changes in innervation and synapse formation. In
addition to causing HC damage, IDPN is also a neurotoxin
targeting neurons in the central and peripheral vestibular systems (Llorens et al., 2011), possibly causing some variability of
VsEP results. Our current model is ideal to further investigate
the significance of each component in future works.
Our study posits Atoh1 as a promising candidate target to
induce regeneration of vestibular sensory organs to restore function. As bona fide HC progenitors, support cells in the damaged
mature utricle may reveal factors conferring Atoh1 responsiveness, which should guide future reprogramming approaches
for inner ear regeneration.
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Mouse: B6.Cg-Tg(Plp1-cre/ERT)3Pop/J

Jackson Laboratory

RRID:IMSR_JAX:005975

Mouse: B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J

Jackson Laboratory

RRID:IMSR_JAX:007908

Mouse: CAG-flox-Atoh1-HA

Liu et al., 2012

n/a

Mouse: Crl:CD1(ICR)

Charles River

RRID:IMSR_CRL:22

50 -ACGCTCTGTCGGAGTTGCTG-30

n/a

Atoh1-HA transgene (forward)

50 -AGGGATAGCCCGCATAGTCA-30

n/a

Atoh1-HA transgene (reverse)

50 -CTAGGCCACAGAATTGAAAGATCT-30

n/a

Plp1-Cre internal positive control (forward)

50 -GTAGGTGGAAATTCTAGCATCC-30

n/a

Plp1-Cre internal positive control (reverse)
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Oligonucleotides
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Continued
REAGENT or RESOURCE
0

5 -GCGGTCTGCCAGTAAAAACTATC-3

0

SOURCE

IDENTIFIER

n/a

Plp1-Cre transgene (forward)

50 -GTGAAACAGCATTGCTGTCACTT-30

n/a

Plp1-Cre transgene (reverse)

50 - CTGTTCCTGTACGGCATGG 30

n/a

tdTomato mutant (forward)

50 - GGCATTAAAGCAGCGTATCC 30

n/a

tdTomato mutant (reverse)

50 -AAGGGAGCTGCAGTGGAGTA-30

n/a

tdTomato wild type (forward)

50 -CCGAAAATCTGTGGGAAGTC-30

n/a

tdTomato wild type (reverse)

Fiji v2.0.0

NIH

n/a

GraphPad Prism v7.0c

GraphPad

n/a

RStudio v0.99.891

RStudio, Inc.

n/a

Sigma-Aldrich

#T5648-1G

Software and Algorithms

Other
PBS
BSA

Thermo Fisher Scientific

#BP1600-100

NaN3

Sigma-Aldrich

#S2002-25G

DAKO

Agilent

#S3023

LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Alan
Cheng (aglcheng@stanford.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Plp1-CreERT (Jackson Laboratory, RRID:IMSR_JAX:005975, Bar Harbor, Maine, USA) (Doerflinger et al., 2003; Gomez-Casati et al.,
2010; Madisen et al., 2010), Rosa26-tdTomato (Jackson Laboratory, RRID:IMSR_JAX:007908, Bar Harbor, Maine, USA) (Madisen
et al., 2010), CAG-flox-Atoh1-HA (gift of J. Zuo, Creighton University, Omaha, Nebraska, USA) (Liu et al., 2012), and wild-type
CD1 (Charles River, RRID:IMSR_CRL:22, Wilmington, Massachusetts, USA) mice of both sexes were used. Littermates were group
housed under standard husbandry conditions and were randomly assigned to experimental groups. All animals were confirmed to be
in good health and not involved in previous procedures. Genotypes of experimental animals included: wild-type CD1, Plp1CreERT/+;
Rosa26tdTomato/+, Plp1CreERT/+; CAGflox-Atoh1-HA/+, and Plp1CreERT/+; CAGflox-Atoh1-HA/+; Rosa26tdTomato/+. IDPN (3,30 -iminodipropionitrile; Pfaltz & Bauer, #I00455, Waterbury, Connecticut, USA) was injected intraperitoneally (IP, 2-6 mg/g) once for adult mice (P30).
Tamoxifen (dissolved in corn oil; #T5648-1G, Sigma-Aldrich, St. Louis, Missouri, USA) (IP, 9 mg/40 g) and EdU (IP, 1 mg/kg, Thermo
Fisher Scientific, #A10044, Waltham, Massachusetts, USA) were used in a subset of mice. Mortality was low (< 5%) with the use of
multiple drugs (4 mg/g IDPN, tamoxifen, EdU) in transgenic (Plp1-Atoh1-HA) animals. Mortality was 50% when 6 mg/g IDPN was
used. No significant differences in either the degree of damage induced by IDPN or subsequent regeneration were observed between
ears or between sexes (data not shown). All protocols conform to relevant regulatory standards and were approved by the Animal
Care and Use Committee of the Stanford University School of Medicine and NIH.
METHOD DETAILS
Genotyping
Genomic DNA of transgenic mice was collected to perform PCRs. DNA was isolated by adding 180 mL of 50 mM sodium hydroxide
(NaOH, Thermo Fisher Scientific, S318-500) to ear biopsies, incubating at 98 C for 1 hour, then adding 20 mL of 1 M Tris-HCl
(Invitrogen, Thermo Fisher Scientific, #15568025). A list of primers and sequences used for genotyping can be found in the Key
Resources Table.
Vestibular physiology
Linear vestibular evoked potential (VsEP) responses were recorded from mice at various ages (P37, P60, P120, P210) as previously
described (Jones and Jones, 1999). Briefly, mice were first anesthetized with a 1:1 cocktail of ketamine (100 mg/kg, #NDC 50989161-06, Vedco, St. Joseph, Missouri, USA) and xylazine (10 mg/kg, #SC-36294Rx, Santa Cruz Animal Health, Dallas, TX, USA).
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Rectal temperatures were maintained at 37 C, and electrocardiographic (ECG) activity was monitored using an oscilloscope.
Subcutaneous stainless-steel electrodes were placed over the caudal cerebrum (non-inverting electrode), subcutaneously behind
the right pinna (inverting electrode), and intramuscularly in the right thigh muscle (ground electrode). A head clip was used to secure
the head to the mechanical shaker, which was used to deliver linear vestibular stimuli in the naso-occipital axis. Vertical motion of the
shaker was monitored with an accelerometer and adjusted to produce the stimulus waveforms. Throughout the study, jerk
stimuli ranging from 0.125 g/ms to 2.0 g/ms were provided (Jones et al., 2011). Signals were amplified (200,000x), filtered (low
filter = 300 Hz, high filter = 3000 Hz), and digitized via an analog-to-digital (A/D) converter for all VsEP recordings. Responses
from normal and inverted stimulus polarities were collected and added together for a total of 256 sweeps for each waveform. A
masker (90 dB SPL; bandwidth 50 Hz to 50 kHz) from a free-field speaker driver was used to prevent responses from the auditory
components of cranial nerve VIII. All responses were blindly analyzed for three components: threshold (g/ms), P1 latency (ms)
and P1-N1 amplitude (mV). Thresholds were defined as the average stimulus intensity between the lowest stimulus intensity at which
a response was observed and the following stimulus intensity that failed to elicit a response. Latencies were measured relative to the
onset of the stimulus for the first positive response peak (P1). Amplitudes represented peak-to-peak magnitudes between P1 and N1.
Whereas the first positive and negative response peaks (P1 and N1, respectively) reflect activity of the peripheral vestibular nerve,
peaks beyond N1 reflect activity of the brainstem and central vestibular relays (Jones, 1992; Nazareth and Jones, 1998).
Immunohistochemistry
After microdissection from the temporal bone, utricles were fixed in 4% paraformaldehyde (in PBS, pH 7.4; Electron Microscopy
Services, #15710, Hatfield, Pennsylvania, USA) for 40 min at room temperature. Tissues were then washed with PBS 3 times for
at least 5 minutes each, then blocked with 5% donkey serum, 0.1% Triton X-100, 1% bovine serum albumin (BSA, Thermo Fisher
Scientific, #BP1600-100), and 0.02% sodium azide (NaN3, Sigma-Aldrich, #S2002-25G) in PBS at pH 7.4 for 1 hour at room temperature. Primary antibodies diluted in the same blocking solution were added overnight at 4 C. The following day, after washing with
PBS, tissues were incubated with secondary antibodies diluted in 0.1% Triton X-100, 0.1% BSA, and 0.02% NaN3 solution in PBS at
pH 7.4 for 2 hours at room temperature. After washing with PBS, tissues were mounted with antifade Fluorescence Mounting Medium
(DAKO, Agilent, #S3023, Santa Clara, California, USA) and coverslipped. Antibodies against the following proteins were used:
Myosin7a (1:1000, rabbit, RRID:AB_2314839, Proteus Biosciences, Ramona, California, USA), Myosin7a (1:500, mouse, DSHB,
RRID:AB_2282417, Iowa City, Iowa, USA), Sox2 (1:400, goat, RRID:AB_2286684, Santa Cruz Biotechnology, Santa Cruz, California,
USA), AnnexinA4 (1:200, goat, RRID:AB_2242796, R&D Systems, Minneapolis, Minnesota, USA), Osteopontin (1:200, goat,
RRID:AB_2194992, R&D Systems), Tuj1 (1:1000, mouse, Neuromics, RRID:AB_2737114, Edina, Minnesota, USA), Neurofilament
(1:1000, chicken, Abcam, RRID:AB_304560, Cambridge, United Kingdom), Ctbp2 (1:1000, mouse, RRID:AB_399431, BD Transduction Laboratories, Franklin Lakes, New Jersey, USA), Shank1 (1:1000, goat, RRID:AB_2301736, Santa Cruz Biotechnology), Ki67
(1:500, rabbit, RRID:AB_302459, Abcam, Cambridge, United Kingdom), Atoh1 (1:2000, rabbit, RRID:AB_10733126, Proteintech,
Rosemont, Illinois, USA) (Atkinson et al., 2018), and HA (1:500, rabbit, RRID:AB_307019, Sigma-Aldrich). Secondary antibodies
included Alexa Fluor donkey anti-goat 488 (RRID:AB_2534102), Alexa Fluor donkey anti-goat 546 (RRID:AB_142628), Alexa Fluor
donkey anti-goat 647 (RRID:AB_141844), Alexa Fluor donkey anti-mouse 488 (RRID:AB_141607), Alexa Fluor donkey anti-mouse 546
(RRID:AB_2534012), Alexa Fluor donkey anti-mouse 647 (RRID:AB_162542), Alexa Fluor donkey anti-rabbit 488 (RRID:AB_2535792)
Alexa Fluor donkey anti-rabbit 546 (RRID:AB_2534016), Alexa Fluor donkey anti-rabbit 647 (RRID:AB_2536183, all Thermo Fisher
Scientific) at 1:250 to 1:500. Fluorescence-conjugated phalloidin (1:1,000; RRID:AB_2620155, Thermo Fisher Scientific), DAPI
(1:10,000 from 5mg/ml stock solution; RRID:AB_2629482, Thermo Fisher Scientific), and Alexa Fluor 647 EdU Detection Kit
(#C10340, Thermo Fisher Scientific) were used. Texas Red-conjugated gentamicin (GTTR) was synthesized as previously described
and applied at 1:200 of stock solution (0.85 mg/mL) for 2 hours (Myrdal et al., 2005; Sandoval et al., 1998).
QUANTIFICATION AND STATISTICAL ANALYSIS
Image acquisition and cell quantification
Low-magnification images were acquired using epifluorescent microscopy (Axioplan 2, Zeiss, Oberkochen, Germany). Highmagnification Z stack images were captured using a 63x objective on a Zeiss LSM 700 or 880 confocal microscope (Zen Black,
Zeiss). Whole utricle images were acquired using tile scanning via Z-stack images tiled across the length and width of the entire
utricle at 63x magnification on the Zeiss LSM 880 confocal microscope. Once the image was captured with Zen Black, it was
transferred to Zen Blue for image processing. The image was then stitched during post-processing to fuse the individual tiles.
From these Z stack images, cell quantification was performed either per 10,000 mm2 or per organ using Fiji software (v2.0.0,
NIH, Bethesda, Maryland, USA). Cell counts were analyzed either from 1-2 representative areas from the extrastriola and striola,
or from merged images spanning the whole utricle (merged together using Zeiss Zen software). Quantification of total HC numbers
represents cell counts from the entire sensory epithelium. For all experiments, n values represent the number of animals or utricles
or cells examined.
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Statistical analyses
Statistical analyses were conducted using GraphPad Prism (v7.0c software, GraphPad, San Diego, CA, USA) and RStudio
(v0.99.891, RStudio, Inc., Boston, MA, USA). Statistical significance was determined using c2 tests, Student’s t tests, or one- or
two-way ANOVA followed by post hoc analysis via Tukey’s multiple comparisons test unless otherwise stated as appropriate.
A p value less than 0.05 was considered significant: *p < 0.05, **p < 0.01, ***p < 0.001. Data are shown as mean ± s.d. Linear regression analysis was performed to quantify goodness of fit via computation of the Pearson correlation coefficient (RStudio). Details of
experiments can be found in the figures and figure legends. Numbers of animals, utricles, or HCs listed in parentheses.
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